Secondary tabs
Contact details
Mui Van Zandt
Main
Hugo Vernooij
Alternate
Publications
Data source publications
Studies
List of studies that have been conducted using the data source
- Drug Utilisation Study of conjugated oestrogens/bazedoxifene (CE/BZA) in the European Union (EU)
- Hydroxychloroquine safety and potential efficacy as an antiviral prophylaxis in light of potential wide-spread use in COVID-19: a multinational, large-scale network cohort and self-controlled case series study
- Study of exposure and use patterns of alternatives to ranitidine-containing medicines in patients treated with ranitidine (Ranitidine)
- DARWIN EU® Prevalence of rare blood cancers in Europe
- DARWIN EU® Drug utilisation of valproate-containing medicinal products in women of childbearing potential
- DARWIN EU® Use of take-home naloxone for opioid overdose treatment
- DARWIN EU® Drug utilization study of prescription opioids
- DARWIN EU® Drug utilisation study of medicines with prokinetic properties in children and adults diagnosed with gastroparesis
- DARWIN EU® Monitoring prescription of medicines for public health emergencies at risk of shortages
- DARWIN EU® – Frailty and polypharmacy among adults with selected cancers at the time of diagnosis
- DARWIN EU® - Drug utilisation study on medicinal use of Pelargonii radix
- DARWIN EU® – Trends in utilisation of Attention-Deficit Hyperactivity Disorder (ADHD) Medications
- DARWIN EU® - Drug Utilisation Study on GLP-1 Receptor Agonists
- DARWIN EU® - Antipsychotic prescribing in the general population in Europe: a descriptive analysis of trends and patient characteristics
- DARWIN EU® - Antipsychotic prescribing in people with dementia in Europe: a descriptive analysis of trends and patient characteristics
- DARWIN EU® – Incidence rates of venous thromboembolic events in patients with selected cancers
- DARWIN EU® - Impact of risk minimisation measures related to the risk of meningioma in women using nomegestrol and chlormadinone
- DARWIN EU® – Monitoring prescription of medicines for public health emergencies at risk of shortages
- DARWIN EU® Drug Utilisation Study of prescription opioids